ValiRx has been granted a patent for its lead therapeutic compound VAL201 for the treatment of breast, prostate, breast and ovarian cancer in Australia.The cancer diagnostics company said VAL201 has shown efficacy in prostate, breast and ovarian cancer ...
[Published BullBearings - Apr 25 2013]